- HealthTech
- Thursday, 16 Apr 2020
Real Time Announces Strategic Partnership with AMS Onsite to Advance Infection Prevention
Real-Time Medical Systems (Real Time), the Interventional Analytics solution in healthcare, announces a strategic partnership with AMS Onsite, a fast-growing infection control management practice. AMS Onsite will embed Real Time's Infection Risk Identification tools into the nursing facilities its serves in order to stay ahead of potential infectious disease outbreaks.
Real Time's industry-leading Interventional Analytics solution extracts live clinical data from the LTPAC EHR and identifies subtle changes in resident condition, pushing live alerts, to clinical teams in an effort to anticipate adverse situations before they occur. Following the emergence of COVID-19, Real Time launched its Infection Risk Identification tools to its 1000+ customers, for remote monitoring. The service identifies early warning signs of infectious diseases through a complex algorithm that includes increased temperature, high respiratory rate, cough and shortness of breath, to detect potential outbreaks in nursing facility communities.
AMS Onsite offers an all-inclusive infection control management program specifically developed for the LTPAC population. Providing certified Infection Preventionists, its team of clinical professionals deliver infection control leadership, support, training, and testing, including COVID-19, to meet infection control regulations and to keep residents safe.
"We are excited to be partnering with AMS Onsite," states Joan Neuscheler, Real Time Chief Executive Officer. "Utilizing Real Time's Infection Risk Identification tools, AMS Onsite's Infection Preventionists can immediately identify possible cases of infectious disease and work with the nursing facilities to prevent further outbreaks."
Patrick Britton-Harr, AMS Onsite Founder and Chief Executive Officer states, "We are very proud to be partnering with Real Time. With the emergence of COVID-19, our Infection Preventionists have also been under stressful moments to help our nursing facilities stay ahead of possible outbreaks. Now, with these live alerts, we can respond hours, if not days faster." Britton-Harr suggests many times the next step from "hotspot" identification is testing, especially for respiratory illnesses. AMS Onsite also provides rapid response testing which recently now includes COVID-19.
Related Industry Updates
Protein Stability Analysis Market Size Growth Forecast 2021 to 2027 | GENERAL ELECTRIC, Thermo Fisher Scientific, PerkinElmer Inc, WATERS, Agilent Technologies, Inc
Mar 12, 2021
Vacuum Therapy Market Opportunity Assessment, Global Demand 2020 to 2027
Dec 16, 2020
WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
Feb 18, 2020
Asia Pacific Anti-Viral Therapies Market To See Tremendous Rise during 2019-2027 with Top Companies Like Aurobindo Pharma Ltd, AbbVie, GlaxoSmithKline, AstraZeneca
Dec 11, 2020
Oral Drug Delivery Market Valuable Growth And Future Scenario Forecast 2020 - 2027
Jan 04, 2021
North America Vaccines Market Size Estimation, Share Value, Future Dynamics, Sales Insights, COVID-19 Impact Analysis and Industry Trends By 2027
Sep 14, 2020
Europe Sinus Dilation Market Report Analysis 2019-2027|Medtronic, Smith And Nephew, Johnson And Johnson Services Inc, Stryker Corporation
Apr 20, 2021